Please provide your email address to receive an email when new articles are posted on . LOUISVILLE, Ky. — Multi-allergen oral immunotherapy may reduce treatment time overall but also led to ...
A clinical trial has found that the medication omalizumab, marketed as Xolair, treated multi-food allergy more effectively than oral immunotherapy (OIT) in people with allergic reactions to very small ...
This is an ASCO Meeting Abstract from the 2018 World Cancer Congress Abstracts. This abstract does not include a full text component.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results